 |
|
Beta-Adrenergic Receptor Blocking Drugs in Psychiatry
James W. Jefferson, MD
Arch Gen Psychiatry. 1974;31(5):681-691.
Abstract
Beta-adrenergic receptor blocking drugs have been employed in a variety of psychiatric conditions with variable success. The beta blockers appear to have an antianxiety action that is best established in the treatment of psychocardiac disorders but is less well defined with regard to other anxiety related conditions. A paucity of studies comparing them with conventional anxiolytic drugs is one reason for not presently recommending their widespread use.
As antipsychotic agents, the beta blockers have shown promise in studies that, at present, must be considered preliminary, while they clearly have potential as tools for investigating the neuropharmacology of psychosis. If future research with these compounds proceeds in an organized, scientific fashion, the beta-adrenergic receptor antagonists will quite likely become established as effective psychotherapeutic drugs.
Author Affiliations
From the Department of Psychiatry, University Hospitals, University of Wisconsin, Madison.
Footnotes
Accepted for publication Aug 12, 1974.
Reprint requests to the Department of Psychiatry, University of Wisconsin, 1300 University Ave, Madison, WI 53706 (Dr. Jefferson).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Treatment of Viral Encephalitis Organic Personality Disorder and Autistic Features with Propranolol: A Case Report
Schmidt et al.
Neurorehabil Neural Repair 1995;9:41-45.
ABSTRACT
Increased Antidepressant Use in Patients Prescribed {beta}-Blockers
Avorn et al.
JAMA 1986;255:357-360.
ABSTRACT
The Anxiety Disorders
BROWN et al.
ANN INTERN MED 1984;100:558-564.
ABSTRACT
Effect of Acute ss-Adrenergic Blockade on Lactate-Induced Panic
Gorman et al.
Arch Gen Psychiatry 1983;40:1079-1082.
ABSTRACT
Evaluation of Propranolol in Opiate Dependence
Resnick et al.
Arch Gen Psychiatry 1976;33:993-997.
ABSTRACT
|
